Cargando…
Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva
The coronavirus disease 2019 (COVID-19) pandemic has become an immense global health crisis. However, the lack of efficient and sensitive on-site testing methods limits early detection for timely isolation and intervention. Here, we present a quantitative and ultrasensitive in situ immunoassay techn...
Autores principales: | Chen, Yuchao, Liu, Fei, Lee, Luke P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132547/ https://www.ncbi.nlm.nih.gov/pubmed/35613342 http://dx.doi.org/10.1126/sciadv.abn3481 |
Ejemplares similares
-
Quantitative and Ultrasensitive In-situ Immunoassay Technology for SARS-CoV-2 Detection in Saliva
por: Chen, Yuchao, et al.
Publicado: (2021) -
A fast, ultrasensitive SERS immunoassay to detect SARS-CoV-2 in saliva
por: Mohammadi, Moein, et al.
Publicado: (2022) -
Tracking the immune response by MRI using biodegradable and ultrasensitive microprobes
por: Martinez de Lizarrondo, Sara, et al.
Publicado: (2022) -
Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes
por: Tang, Mei, et al.
Publicado: (2022) -
Comparison of replicating and nonreplicating vaccines against SARS-CoV-2
por: Mudrick, Haley E., et al.
Publicado: (2022)